Topic: Albert Borla

1 chapters across the catalog

Jason Bermas discusses the commercialization of brain-machine interfaces following the first human Neuralink implant. He connects this to the "Internet of Bodies" and the FDA-approved "Abilify MyCite" system, which features a digital tracking chip inside a pill to ensure patient compliance. Pfizer CEO Albert Bourla is shown at Davos discussing the "biological chip" technology as a tool for insurance companies and healthcare providers to monitor medication intake.